Shareholders’ Equity	9 Months Ended
Sep. 30, 2026
Accounting Policies [Abstract]
Shareholders’ Equity	NOTE 8 — Shareholders’ Equity Common Stock The Company has 75,000,000 common shares authorized with a par value of $0.001 per share. On December 10, 2025, we issued 1,800,000 shares of common stock to Alexander Valencia Pena, our President, Secretary, Treasurer and a Director, at a price of $0.005 per share, for an aggregate value of $9,000. In July 2026 the Company issued 68,000 common shares to its shareholders for total proceeds of $1,700, representing approximately $0.025 per share. In August 2026 the Company issued 97,800 common shares to its shareholders for total proceeds of $2,445, representing approximately $0.025 per share. 15 In September 2026 the Company issued 196,200 common shares to its shareholders for total proceeds of $4,905, representing approximately $0.025 per share. There were 2,162,000 and 1,800,000 shares of common stock issued and outstanding as of September 30, 2026, and December 31, 2025, respectively. Preferred Stock No preferred stocks were issued or outstanding as of September 30, 2026. Warrants No warrants were issued or outstanding as of September 30, 2026. Stock Options No stock options were issued or outstanding as of September 30, 2026. Accumulated Deficit As of September 30, 2026, accumulated deficit was $31,399, compared to $14,478 as of December 31, 2025. The change in accumulated deficit during the nine months ended September 30, 2026, primarily resulted from the Company’s net loss for the period.

Shareholders’ Equity

9 Months Ended

Sep. 30, 2026

NOTE 8 — Shareholders’ Equity

Common Stock

The Company has 75,000,000 common shares authorized with a par value of $0.001 per share.

On December 10, 2025, we issued 1,800,000 shares of common stock to Alexander Valencia Pena, our President, Secretary, Treasurer and a Director, at a price of $0.005 per share, for an aggregate value of $9,000.

In July 2026 the Company issued 68,000 common shares to its shareholders for total proceeds of $1,700, representing approximately $0.025 per share.

In August 2026 the Company issued 97,800 common shares to its shareholders for total proceeds of $2,445, representing approximately $0.025 per share.

In September 2026 the Company issued 196,200 common shares to its shareholders for total proceeds of $4,905, representing approximately $0.025 per share.

There were 2,162,000 and 1,800,000 shares of common stock issued and outstanding as of September 30, 2026, and December 31, 2025, respectively.

Preferred Stock

No preferred stocks were issued or outstanding as of September 30, 2026.

Warrants

No warrants were issued or outstanding as of September 30, 2026.

Stock Options

No stock options were issued or outstanding as of September 30, 2026.

Accumulated Deficit

As of September 30, 2026, accumulated deficit was $31,399, compared to $14,478 as of December 31, 2025. The change in accumulated deficit during the nine months ended September 30, 2026, primarily resulted from the Company’s net loss for the period.